Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „OATP1B1“
Suchtreffer
Begriffe & Kennungen
Aprovel · 4.5 · Repaglinide: irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesa
Eintrag öffnenAprovel · 4.5 · Repaglinide: irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesa
Eintrag öffnenAprovel · 4.5 · Repaglinide: irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesa
Eintrag öffnenAprovel · 4.5 · Repaglinide: irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesa
Eintrag öffnenAprovel · 4.5 · Repaglinide: irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesa
Eintrag öffnenAprovel · 4.5 · Repaglinide: irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesa
Eintrag öffnenAubagio · 4.5 · Effect of teriflunomide on BCRP and /or organic anion transporting polypeptide B1 and B3 (OATP1B1/B3) substrat
Eintrag öffnenBraftovi · 4.5 · Transporter substrates In vivo, encorafenib is an inhibitor of OATP1B1, OATP1B3 and/or BCRP. Coadministration
Eintrag öffnenCabazitaxel Accord · 4.5 · 6 OATP1B1 In vitro, cabazitaxel has also been shown to inhibit the transport proteins of the Organic Anion Tra
Eintrag öffnenCelsentri · 4.5 · Maraviroc is a substrate for the transporters P-glycoprotein and OATP1B1, but the effect of these transporters
Eintrag öffnenCelsentri · 4.5 · Maraviroc is a substrate for the transporters P-glycoprotein and OATP1B1, but the effect of these transporters
Eintrag öffnenCoAprovel · 4.5 · Repaglinide: irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesa
Eintrag öffnenCoAprovel · 4.5 · Repaglinide: irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesa
Eintrag öffnenCoAprovel · 4.5 · Repaglinide: irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesa
Eintrag öffnenCoAprovel · 4.5 · Repaglinide: irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesa
Eintrag öffnenCoAprovel · 4.5 · Repaglinide: irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesa
Eintrag öffnenCotellic · 4.5 · In vitro studies show that cobimetinib is not a substrate of the liver uptake transporters OATP1B1, OATP1B3 an
Eintrag öffnenDarunavir Viatris (previously Darunavir Mylan) · 4.5 · 49 OATP1B1 and OATP1B3 (see contraindications and recommendations presented in the section above). Cobicistat
Eintrag öffnenDarunavir Viatris (previously Darunavir Mylan) · 4.5 · Ritonavir inhibits the transporters P-glycoprotein, OATP1B1 and OATP1B3, and co-administration with substrates
Eintrag öffnenDarunavir Viatris (previously Darunavir Mylan) · 4.5 · Ritonavir inhibits the transporters P-glycoprotein, OATP1B1 and OATP1B3, and co-administration with substrates
Eintrag öffnen